Public health experts are sounding alarms over a resurgence of measles in Bangladesh, where a significant outbreak has led to numerous child deaths, underscoring the critical impact of vaccine shortages. The nation, which had previously made substantial strides in controlling the disease, is now grappling with an overwhelmed healthcare system.
In areas outside the capital, Dhaka, the consequences of a lack of available vaccines have become starkly evident. One parent recounted taking their 10-month-old child, Maliha, for a scheduled vaccination in February, only to be told that no vaccines were left. By late March, as the outbreak intensified, Maliha was hospitalized with pneumonia. Her condition worsened, and her parents noticed a rash, a hallmark symptom of measles.
Access to care proved challenging, with reports of bed shortages in hospitals. Maliha's parents claim that children with and without measles were treated in the same wards. "No matter how much we wiped her body down, her fever didn't come down," one parent stated. The need for an Intensive Care Unit (ICU) bed became apparent, but none were available. Hours were spent traveling in an ambulance as Maliha struggled to breathe, until a bed was finally secured.
Maliha died three days later. Her parent expressed grief and questioned accountability, asking, "Should I blame the government because my child did not get the vaccine?"
More than 120,000 suspected and confirmed measles cases have been reported in Bangladesh. The ongoing outbreak has placed immense strain on healthcare facilities, highlighting the fragility of public health gains when immunization programs are disrupted. Public health experts emphasize that such crises serve as a potent reminder of the necessity for consistent and widespread vaccine coverage to prevent preventable diseases. 
